João Miguel Sanches

João Miguel Sanches


Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2018 in Computer Methods and Programs in Biomedicine
Verified
Journal Article
Closed access
MBMainak Biswas
Mainak Biswas
VKVenkata Naresh Babu Kuppili
Venkata Naresh Babu Kuppili
DEDamodar Reddy Edla
Damodar Reddy Edla
HSHarman S. Suri
Harman S. Suri
LSLuca Saba
Luca Saba
Jasjit SuriJasjit Suri
Jasjit Suri

1 July 2016 in Computer Methods and Programs in Biomedicine
Verified
Journal Article
Closed access
LSLuca Saba
Luca Saba
Nilanjan DeyNilanjan Dey
Nilanjan Dey
AAAmira Ashour
Amira Ashour
SSSourav Samanta
Sourav Samanta
SNSiddhartha Sankar Nath
Siddhartha Sankar Nath
Jasjit SuriJasjit Suri
Jasjit Suri

23 August 2017 in Journal of Medical Systems
Verified
Journal Article
Closed access
PDF file
VKVenkata Naresh Babu Kuppili
Venkata Naresh Babu Kuppili
MBMainak Biswas
Mainak Biswas
ASAswini Sreekumar
Aswini Sreekumar
HSHarman S. Suri
Harman S. Suri
LSLuca Saba
Luca Saba
Jasjit SuriJasjit Suri
Jasjit Suri

20 July 2015 in Oncogene
Verified
Journal Article
Open access
PDF file
SCSandra Carvalho
Sandra Carvalho
TCT A Catarino
T A Catarino
ADA M Dias
A M Dias
MKM Kato
M Kato
AAA Almeida
A Almeida
SPSalomé Pinho
Salomé Pinho
E-cadherin is a central molecule in the process of gastric carcinogenesis and its posttranslational modifications by N-glycosylation have been described to induce a deleterious effect on cell adhesion associated with tumor cell invasion. However, the role that site-specific glycosylation of E-cadherin has in its defective function in gastric cancer cells needs to be determined. Using transgenic mice models and human clinical samples, we demonstrated that N-acetylglucosaminyltransferase V (GnT-V)-mediated glycosylation causes an abnormal pattern of E-cadherin expression in the gastric mucosa. In vitro models further indicated that, among the four potential N-glycosylation sites of E-cadherin, Asn-554 is the key site that is selectively modified with β1,6 GlcNAc-branched N-glycans catalyzed by GnT-V. This aberrant glycan modification on this specific asparagine site of E-cadherin was demonstrated to affect its critical functions in gastric cancer cells by affecting E-cadherin cellular localization, cis-dimer formation, molecular assembly and stability of the adherens junctions and cell–cell aggregation, which was further observed in human gastric carcinomas. Interestingly, manipulating this site-specific glycosylation, by preventing Asn-554 from receiving the deleterious branched structures, either by a mutation or by silencing GnT-V, resulted in a protective effect on E-cadherin, precluding its functional dysregulation and contributing to tumor suppression.

22 June 2012 in Medical Physics
Verified
Journal Article
Closed access
U Rajendra AcharyaU Rajendra Acharya
U Rajendra Acharya
VSVinithasree Subbhuraam
Vinithasree Subbhuraam
RRRicardo Ribeiro
Ricardo Ribeiro
GKGanapathy Krishnamurthi
Ganapathy Krishnamurthi
RMRui Tato Marinho
Rui Tato Marinho
JSJasjit S. Suri
Jasjit S. Suri

6 January 2013 in Medical & Biological Engineering & Computing
Verified
Journal Article
Closed access
PDF file
U Rajendra AcharyaU Rajendra Acharya
U Rajendra Acharya
Muthu Rama Krishnan MookiahMuthu Rama Krishnan Mookiah
Muthu Rama Krishnan Mookiah
VSVinithasree Subbhuraam
Vinithasree Subbhuraam
DADavid Afonso
David Afonso
JSJoão Miguel Sanches
João Miguel Sanches
Jasjit SuriJasjit Suri
Jasjit Suri